Investors Buy Large Volume of Perrigo Call Options (NYSE:PRGO)

Perrigo Company plc (NYSE:PRGO) was the recipient of unusually large options trading on Tuesday. Stock traders purchased 5,051 call options on the stock. This represents an increase of approximately 567% compared to the typical volume of 757 call options.

Institutional Investors Weigh In On Perrigo

Several institutional investors have recently modified their holdings of PRGO. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Perrigo by 291.9% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 7,824,759 shares of the company’s stock valued at $108,921,000 after purchasing an additional 5,828,076 shares during the last quarter. Norges Bank bought a new stake in shares of Perrigo in the 4th quarter valued at approximately $42,607,000. Invesco Ltd. lifted its stake in shares of Perrigo by 134.2% in the 4th quarter. Invesco Ltd. now owns 4,542,415 shares of the company’s stock valued at $63,230,000 after purchasing an additional 2,602,724 shares during the last quarter. ION Fund Management Ltd bought a new stake in shares of Perrigo in the 4th quarter valued at approximately $24,499,000. Finally, Perpetual Ltd lifted its stake in shares of Perrigo by 64.2% in the 3rd quarter. Perpetual Ltd now owns 3,149,878 shares of the company’s stock valued at $70,148,000 after purchasing an additional 1,231,400 shares during the last quarter. 95.91% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

PRGO has been the subject of several research analyst reports. Jefferies Financial Group reiterated a “hold” rating on shares of Perrigo in a research report on Thursday, February 26th. Canaccord Genuity Group dropped their price target on Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a research note on Friday, February 27th. JPMorgan Chase & Co. dropped their price target on Perrigo from $20.00 to $18.00 and set a “neutral” rating for the company in a research note on Monday, December 15th. Argus raised Perrigo to a “hold” rating in a research note on Wednesday, January 14th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Perrigo in a research note on Monday, December 22nd. One investment analyst has rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, Perrigo has an average rating of “Reduce” and an average target price of $19.33.

Perrigo Price Performance

Shares of Perrigo stock opened at $10.54 on Wednesday. The stock has a 50 day moving average of $12.16 and a 200 day moving average of $15.01. Perrigo has a 12 month low of $9.23 and a 12 month high of $28.43. The firm has a market cap of $1.45 billion, a PE ratio of -1.03, a PEG ratio of 1.27 and a beta of 0.47. The company has a current ratio of 2.76, a quick ratio of 1.63 and a debt-to-equity ratio of 1.23.

Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Thursday, February 26th. The company reported $0.77 EPS for the quarter, missing analysts’ consensus estimates of $0.80 by ($0.03). Perrigo had a negative net margin of 33.51% and a positive return on equity of 9.41%. The firm had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the previous year, the company posted $0.93 earnings per share. Perrigo’s quarterly revenue was down 2.5% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, research analysts expect that Perrigo will post 2.56 EPS for the current fiscal year.

Perrigo Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 24th. Stockholders of record on Monday, March 2nd were paid a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 11.0%. The ex-dividend date of this dividend was Monday, March 2nd. Perrigo’s dividend payout ratio (DPR) is presently -11.28%.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.